Market Cap 580.14B
Revenue (ttm) 94.19B
Net Income (ttm) 26.80B
EPS (ttm) N/A
PE Ratio 22.28
Forward PE 20.67
Profit Margin 28.46%
Debt to Equity Ratio 0.46
Volume 16,200,569
Avg Vol 8,112,154
Day's Range N/A - N/A
Shares Out 2.41B
Stochastic %K 84%
Beta 0.26
Analysts Strong Sell
Price Target $260.46

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospit...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 732 524 0400
Website: www.jnj.com
Address:
One Johnson & Johnson Plaza, New Brunswick, United States
GettnFibbywIT
GettnFibbywIT Jun. 26 at 9:06 PM
$JNJ Textbook
0 · Reply
TroyTiger
TroyTiger Jun. 26 at 8:51 PM
$TGTX This is trading like a stock about to be bought out. I still think $JNJ is the one, as their stock is at all-time highs.
0 · Reply
BreakoutLife
BreakoutLife Jun. 26 at 8:50 PM
Nasdaq just logged its 5th straight down session - and this one is clearly being driven by a rapid sentiment reset in AI + semis. The catalyst: reports that OpenAI may delay its IPO into next year. That single headline is now being interpreted as a signal that the pace of AI infrastructure financing could slow, not just a corporate timing issue. That’s where the spillover starts: $MU -4% $INTC -3% $AMD -2% SoftBank -12% in Tokyo Kospi -5.8% - broad Asia risk-off move What you’re seeing is not just stock-specific weakness - it’s a global de-risking of the AI capex trade, with JPMorgan even flagging potential sustainability concerns if capital markets funding slows. And as usual in late-cycle rotations, money isn’t leaving the market - it’s rotating: $LLY +7%, $JNJ +3%, defensives, staples, utilities all catching flows. Adding macro pressure: Kashkari signaling potential additional rate hike risk due to inflation tied to geopolitical shocks - which doesn’t help growth duration multiples either. Feels like one of those moments where the AI trade doesn’t break… it just gets repriced.
0 · Reply
notreload_ai
notreload_ai Jun. 26 at 7:54 PM
BREAKING: $ABBV, $LLY and $JNJ shares are on track to reach all-time highs.
0 · Reply
TalkMarkets
TalkMarkets Jun. 26 at 6:33 PM
Stocks Look To Reverse Losses And Finish Friday On High Note $HPE $JNJ $LYFT $NDX $SPX https://talkmarkets.com/article/stocks-look-to-reverse-losses-and-finish-friday-on-high-note-1782498738
0 · Reply
PittsburghTrader
PittsburghTrader Jun. 26 at 6:08 PM
$JNJ wow, didn’t expect this strength after getting a nice bid yesterday
0 · Reply
usiv
usiv Jun. 26 at 5:43 PM
$JNJ $LLY $ABBV looking to close monthly candle on high note
0 · Reply
focafoca99
focafoca99 Jun. 26 at 4:45 PM
$JNJ presented new IMAAVY data at the EAN 2026 Congress, showing sustained disease control in generalized myasthenia gravis. https://www.rapidticker.com/news/jnj-johnson-johnson-presents-new-imaavy-0ac67c
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 26 at 4:35 PM
$JNJ Current Stock Price: $253.00 Contracts to trade: $252.5 JNJ Jun 26 2026 Call Entry: $0.94 Exit: $1.21 ROI: 29% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
BarkingPuppy
BarkingPuppy Jun. 26 at 3:20 PM
0 · Reply
Latest News on JNJ
Johnson & Johnson presents first results from ENERGY study

2026-06-11T09:26:54.000Z - 15 days ago

Johnson & Johnson presents first results from ENERGY study


Johnson & Johnson to Buy Firefly Bio for $1 Billion

Jun 8, 2026, 9:01 AM EDT - 18 days ago

Johnson & Johnson to Buy Firefly Bio for $1 Billion


Johnson & Johnson to acquire Firefly Bio for $1B in cash

2026-06-08T12:14:56.000Z - 18 days ago

Johnson & Johnson to acquire Firefly Bio for $1B in cash


Johnson & Johnson to buy Firefly Bio for $1 billion

Jun 8, 2026, 8:08 AM EDT - 18 days ago

Johnson & Johnson to buy Firefly Bio for $1 billion


Johnson & Johnson says nipocalimab approved in China

May 21, 2026, 4:31 AM EDT - 5 weeks ago

Johnson & Johnson says nipocalimab approved in China


CVS to drop J&J's Stelara from its main formularies

May 5, 2026, 9:15 AM EDT - 7 weeks ago

CVS to drop J&J's Stelara from its main formularies

CVS


J&J's $1.7 Billion Drug Ushers in Age of Psychedelic Medicine

May 2, 2026, 4:00 AM EDT - 7 weeks ago

J&J's $1.7 Billion Drug Ushers in Age of Psychedelic Medicine


Why These 3 Forever Stocks Belong on Your Watchlist

Apr 28, 2026, 11:10 AM EDT - 2 months ago

Why These 3 Forever Stocks Belong on Your Watchlist

WMT XOM


J&J sees AI halving the time to generate drug development leads

Apr 27, 2026, 11:03 AM EDT - 2 months ago

J&J sees AI halving the time to generate drug development leads


GettnFibbywIT
GettnFibbywIT Jun. 26 at 9:06 PM
$JNJ Textbook
0 · Reply
TroyTiger
TroyTiger Jun. 26 at 8:51 PM
$TGTX This is trading like a stock about to be bought out. I still think $JNJ is the one, as their stock is at all-time highs.
0 · Reply
BreakoutLife
BreakoutLife Jun. 26 at 8:50 PM
Nasdaq just logged its 5th straight down session - and this one is clearly being driven by a rapid sentiment reset in AI + semis. The catalyst: reports that OpenAI may delay its IPO into next year. That single headline is now being interpreted as a signal that the pace of AI infrastructure financing could slow, not just a corporate timing issue. That’s where the spillover starts: $MU -4% $INTC -3% $AMD -2% SoftBank -12% in Tokyo Kospi -5.8% - broad Asia risk-off move What you’re seeing is not just stock-specific weakness - it’s a global de-risking of the AI capex trade, with JPMorgan even flagging potential sustainability concerns if capital markets funding slows. And as usual in late-cycle rotations, money isn’t leaving the market - it’s rotating: $LLY +7%, $JNJ +3%, defensives, staples, utilities all catching flows. Adding macro pressure: Kashkari signaling potential additional rate hike risk due to inflation tied to geopolitical shocks - which doesn’t help growth duration multiples either. Feels like one of those moments where the AI trade doesn’t break… it just gets repriced.
0 · Reply
notreload_ai
notreload_ai Jun. 26 at 7:54 PM
BREAKING: $ABBV, $LLY and $JNJ shares are on track to reach all-time highs.
0 · Reply
TalkMarkets
TalkMarkets Jun. 26 at 6:33 PM
Stocks Look To Reverse Losses And Finish Friday On High Note $HPE $JNJ $LYFT $NDX $SPX https://talkmarkets.com/article/stocks-look-to-reverse-losses-and-finish-friday-on-high-note-1782498738
0 · Reply
PittsburghTrader
PittsburghTrader Jun. 26 at 6:08 PM
$JNJ wow, didn’t expect this strength after getting a nice bid yesterday
0 · Reply
usiv
usiv Jun. 26 at 5:43 PM
$JNJ $LLY $ABBV looking to close monthly candle on high note
0 · Reply
focafoca99
focafoca99 Jun. 26 at 4:45 PM
$JNJ presented new IMAAVY data at the EAN 2026 Congress, showing sustained disease control in generalized myasthenia gravis. https://www.rapidticker.com/news/jnj-johnson-johnson-presents-new-imaavy-0ac67c
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 26 at 4:35 PM
$JNJ Current Stock Price: $253.00 Contracts to trade: $252.5 JNJ Jun 26 2026 Call Entry: $0.94 Exit: $1.21 ROI: 29% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
BarkingPuppy
BarkingPuppy Jun. 26 at 3:20 PM
0 · Reply
BarkingPuppy
BarkingPuppy Jun. 26 at 3:16 PM
$DJT $GME $JNJ Go Elite.... ELTP....
0 · Reply
BarkingPuppy
BarkingPuppy Jun. 26 at 3:15 PM
0 · Reply
PrnceMichael
PrnceMichael Jun. 26 at 3:15 PM
$AIMN The right network. The right context. @AimwellBIO Observer connects serious healthcare professionals to trusted signals, curated intelligence, and a verified network built for the future of healthcare. Apply free. Stay in the network. http://aimwellbio.com/observer-signup $AIMN #pharma $PFE $JNJ $MEDI
0 · Reply
TraderDaKing
TraderDaKing Jun. 26 at 3:00 PM
$ELTP $BAC $JNJ $PFE There is a big deal with Elite Pharmaceuticals...... The system is loading with buy orders, Merger, Buyout Next week is earnings and news.
1 · Reply
TraderDaKing
TraderDaKing Jun. 26 at 2:51 PM
0 · Reply
RunnerSignals
RunnerSignals Jun. 26 at 2:42 PM
52-week highs are hiding in defensives ​$WOW $SLS $MRK $JNJ $WELL strength is rotating into cash-flow names while traders keep staring at beta
0 · Reply
BarkingPuppy
BarkingPuppy Jun. 26 at 2:15 PM
0 · Reply
Jamtrades
Jamtrades Jun. 26 at 2:11 PM
Dormant shorts are getting lit up in Pharma names. They are screwed .. $JNJ and $LLY squeeze continues violently as investors seek alpha on this rebalancing day $DIA $SPY
0 · Reply
BarkingPuppy
BarkingPuppy Jun. 26 at 2:10 PM
$ELTP $WEN $PFE $JNJ Big News coming next Week, Earning Monday......... Elite Pharmaceuticals (stock ticker: ELTP) stands out as a remarkable stock with strong fundamentals and promising potential. Recently trading around $0.38 to $0.40, ELTP has shown positive momentum with gains over 1.5% to 5% in recent sessions. The company boasts a solid market capitalization near $400 million and a reasonable price-to-earnings ratio around 10, indicating good value relative to earnings. Despite some recent stock fluctuations, ELTP has demonstrated solid quarterly earnings and revenue performance, underscoring its operational strength. For investors looking for a promising pharmaceutical stock with growth potential and solid financials, ELTP is definitely worth attention.
0 · Reply
vanguard100
vanguard100 Jun. 26 at 2:08 PM
$JNJ 0DTE calls up over 300%..
0 · Reply
E458
E458 Jun. 26 at 2:03 PM
$SPY when the market should be falling but isnt its always these heroes: $JNJ $LLY and then some random tech giant like $MSFT or $AAPL
0 · Reply
frb1985
frb1985 Jun. 26 at 1:56 PM
$JNJ wait what is that a new high. LOL
0 · Reply